Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 1,594,713 $ 2,078,471 $ 3,248,082 $ 3,756,403
General and administrative 733,496 684,877 1,605,171 1,464,131
Total operating expenses 2,328,209 2,763,348 4,853,253 5,220,534
Loss from operations (2,328,209) (2,763,348) (4,853,253) (5,220,534)
Interest income 128,218 417 218,706 881
Net loss (2,199,991) (2,762,931) (4,634,547) (5,219,653)
Other comprehensive income (loss):        
Foreign currency translation gain (loss ) (4,385) 21,210 (15,184) 20,626
Unrealized gain (loss) on investments (20,180) 0 13,464 0
Comprehensive loss $ (2,224,556) $ (2,741,721) $ (4,636,267) $ (5,199,027)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.16) $ (0.22) $ (0.35) $ (0.41)
Weighted average shares outstanding:        
Basic and diluted (in shares) 13,420,029 12,632,381 13,263,770 12,618,489